Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M224Revenue (TTM) $M46.3Net Margin (%)-109.6Altman Z-Score-6.6
Enterprise Value $M219EPS (TTM) $-0.7Operating Margin %-95.3Piotroski F-Score2
P/E(ttm)--Beneish M-Score-1.4Pre-tax Margin (%)-109.6Higher ROA y-yY
Price/Book8.110-y EBITDA Growth Rate %-7.2Quick Ratio0.8Cash flow > EarningsY
Price/Sales5.05-y EBITDA Growth Rate %-10.9Current Ratio0.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-90.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.7ROIC % (ttm)-194.6Gross Margin Increase y-yN

Gurus Latest Trades with BCRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRXJohn Paulson 2016-03-31 Buy 0.01%$1.66 - $10.32
($4.53)
$ 3.04-33%New holding263,100
BCRXJoel Greenblatt 2016-03-31 Sold Out $1.66 - $10.32
($4.53)
$ 3.04-33%Sold Out0
BCRXJoel Greenblatt 2015-12-31 Buy $8.28 - $12.44
($9.93)
$ 3.04-69%New holding19,424
BCRXGeorge Soros 2014-06-30 Sold Out -0.01%$7.37 - $12.52
($9.68)
$ 3.04-69%Sold Out0
BCRXGeorge Soros 2014-03-31 Buy 0.01%$7.6 - $12.83
($10.56)
$ 3.04-71%New holding59,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAKER BROS. ADVISORS LP10% Owner 2016-02-05Buy45,000$6.33-51.97view
BAKER BROS. ADVISORS LP10% Owner 2016-02-04Buy207,715$6.43-52.72view
BAKER BROS. ADVISORS LP10% Owner 2016-01-28Buy88,345$6.95-56.26view
BAKER BROS. ADVISORS LP10% Owner 2016-01-22Buy106,800$7.28-58.24view
BAKER BROS. ADVISORS LP10% Owner 2016-01-20Buy344,895$7.28-58.24view
STAAB THOMAS R IISenior Vice President and CFO 2015-12-21Sell3,052$10.86-72.01view
STAAB THOMAS R IISenior Vice President and CFO 2015-12-17Sell3,000$10.49-71.02view
STAAB THOMAS R IISenior Vice President and CFO 2015-07-20Sell3,500$16.5-81.58view
STAAB THOMAS R IISenior Vice President and CFO 2015-06-22Sell3,750$16-81view
Barnes Alane PVP, General Counsel & Corp Sec 2015-06-19Sell3,000$15-79.73view

Quarterly/Annual Reports about BCRX:

News about BCRX:

Articles On GuruFocus.com
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K/A) Jan 19 2011 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 2,500 Shares Aug 06 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares Jun 04 2010 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares May 05 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 38,553 Shares Apr 30 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,249 Shares Apr 06 2010 

More From Other Websites
BioCryst to Announce Second Quarter 2016 Financial Results August 4 Jul 21 2016
ETF’s with exposure to BioCryst Pharmaceuticals, Inc. : July 7, 2016 Jul 07 2016
BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Jul 05 2016
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic... Jul 05 2016
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic... Jul 05 2016
Most Popular Healthcare Stocks Under $5 May 31 2016
Early Morning Technical Highlights on Biotech Stocks May 31 2016
ETF’s with exposure to BioCryst Pharmaceuticals, Inc. : May 26, 2016 May 26 2016
BioCryst to Present at Two Upcoming Investor Conferences May 26 2016
BioCryst to Present at Two Upcoming Investor Conferences May 26 2016
BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers,... May 25 2016
Biotech-Focused VHCP Management’s Bullish Moves and New Picks May 24 2016
BIOCRYST PHARMACEUTICALS INC Financials May 17 2016
ETF’s with exposure to BioCryst Pharmaceuticals, Inc. : May 12, 2016 May 12 2016
BioCryst Pharmaceuticals, Inc. :BCRX-US: Earnings Analysis: Q1, 2016 By the Numbers May 11 2016
Edited Transcript of BCRX earnings conference call or presentation 5-May-16 3:00pm GMT May 09 2016
BIOCRYST PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 09 2016
BioCryst reports 1Q loss May 05 2016
BioCryst reports 1Q loss May 05 2016
BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)